Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients.

---

Cimen A. O., Emet S., Elitok A.

European review for medical and pharmacological sciences, cilt.23, sa.1, ss.338-342, 2019 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 23 Sayı: 1
• Basım Tarihi: 2019
• Doi Numarası: 10.26355/eurrev_201901_16781
• Dergi Adı: European review for medical and pharmacological sciences
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.338-342
• İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Endothelial specific molecule 1 (Endocan) is a biomarker of the inflammatory process occurring in endothelial cells. It was shown that endocan was increased in acute coronary syndromes. We aimed at investigating the endocan levels in acute coronary syndrome patients after coronary bypass surgery.